Lefelsiran sodium

N/A

Report date: 2024/10/30 10:57:12
NME

Base Information

Drug NameLefelsiran sodium
Drug Alias NameDCR-AUD(Dicerna Pharmaceuticals)DCR-A1203NN 6020NN6020
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceAldehyde dehydrogenase inhibitors
TargetsAldehyde dehydrogenase
Therapy Area/IndicationsAlcoholismAlcohol-Related DisordersChronic Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDicerna Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SDicerna Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAlcoholismAlcohol-Related DisordersChronic Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A